Baseline Spleen Volume is Independently Associated With Survival After CD19‐Directed Chimeric Antigen Receptor T‐Cell Therapy in Relapsed/Refractory Diffuse Large B‐Cell Lymphoma
- DOI
- 10.1002/hon.70284
- Published
- 2026-11
- Container
- Hematological Oncology
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/hon.70284,
title = {Baseline Spleen Volume is Independently Associated With Survival After CD19‐Directed Chimeric Antigen Receptor T‐Cell Therapy in Relapsed/Refractory Diffuse Large B‐Cell Lymphoma},
author = {Lucas Brehm and Philipp Schindler and Christian Römer and Akhil Behringer and Valeria Carobin and Georg Evers and Cyrus Khandanpour and Julia Marx and Christian Reicherts and Jörn Albring and Matthias Stelljes and Evgenii Shumilov and Georg Lenz and Alexander Pohlmann},
year = {2026},
journal = {Hematological Oncology},
doi = {10.1002/hon.70284},
url = {https://doi.org/10.1002/hon.70284}
}RIS
TY - JOUR TI - Baseline Spleen Volume is Independently Associated With Survival After CD19‐Directed Chimeric Antigen Receptor T‐Cell Therapy in Relapsed/Refractory Diffuse Large B‐Cell Lymphoma AU - Lucas Brehm AU - Philipp Schindler AU - Christian Römer AU - Akhil Behringer AU - Valeria Carobin AU - Georg Evers AU - Cyrus Khandanpour AU - Julia Marx AU - Christian Reicherts AU - Jörn Albring AU - Matthias Stelljes AU - Evgenii Shumilov AU - Georg Lenz AU - Alexander Pohlmann PY - 2026 JO - Hematological Oncology DO - 10.1002/hon.70284 UR - https://doi.org/10.1002/hon.70284 ER -
APA
Brehm, L., Schindler, P., Römer, C., Behringer, A., Carobin, V., Evers, G., Khandanpour, C., Marx, J., Reicherts, C., Albring, J., Stelljes, M., Shumilov, E., Lenz, G., & Pohlmann, A. (2026). Baseline Spleen Volume is Independently Associated With Survival After CD19‐Directed Chimeric Antigen Receptor T‐Cell Therapy in Relapsed/Refractory Diffuse Large B‐Cell Lymphoma. Hematological Oncology. https://doi.org/10.1002/hon.70284
Source records
- crossref · retrieved 2026-11-04T17:18:25.486Z